 Connection
Nicholas Foreman to Neoplasms
This is a "connection" page, showing publications Nicholas Foreman has written about Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.209 |
|
|
|
-
Dunkel IJ, Doz F, Foreman NK, Hargrave D, Lassaletta A, Andr? N, Hansford JR, Hassall T, Eyrich M, Gururangan S, Bartels U, Gajjar A, Howell L, Warad D, Pacius M, Tam R, Wang Y, Zhu L, Cohen K. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908. Neuro Oncol. 2023 08 03; 25(8):1530-1545.
Score: 0.085
-
Foreman NK, Thorne RN, Mott MG. Variation in survival of children with cancer within a region of the United Kingdom. Cancer. 1996 Feb 15; 77(4):785-90.
Score: 0.051
-
Foreman NK, Thorne R, Berry PJ, Oakhill A, Mott MG. Childhood malignancies in the south-west region of England, 1976-1985. Med Pediatr Oncol. 1994; 23(1):14-9.
Score: 0.044
-
Sidhu RS, Orsini E, Giller R, Quinones R, Foreman NK, Thompson H, Brimhall B, Walton K, Croskell M, Le TN. Midpoint CD34 measurement as a predictor of PBPC product yield in pediatric patients undergoing high-dose chemotherapy. J Clin Apher. 2006 Oct; 21(3):165-8.
Score: 0.026
-
Thorne R, Foreman NK, Mott MG. Radon in Devon and Cornwall and paediatric malignancies. Eur J Cancer. 1996 Feb; 32A(2):282-5.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|